Aethlon Medical (Aethlon Medical) LT-Debt-to-Total-Asset : 0.07 (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Aethlon Medical LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Aethlon Medical's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.07.

Aethlon Medical's long-term debt to total assets ratio increased from Dec. 2022 (0.05) to Dec. 2023 (0.07). It may suggest that Aethlon Medical is progressively becoming more dependent on debt to grow their business.

Aethlon Medical LT-Debt-to-Total-Asset Historical Data

The historical data trend for Aethlon Medical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aethlon Medical LT-Debt-to-Total-Asset Chart

Aethlon Medical Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.03

0.05

Aethlon Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.05	0.05	0.06	0.06	0.07

Aethlon Medical LT-Debt-to-Total-Asset Calculation

Aethlon Medical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (A: Mar. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2023 )	/	Total Assets (A: Mar. 2023 )
	=	0.94	/	17.509
	=	0.05

Aethlon Medical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0.725	/	10.437
	=

Aethlon Medical (NAS:AEMD) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Aethlon Medical LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Aethlon Medical's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Aethlon Medical (Aethlon Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aethlon Medical Inc (NAS:AEMD) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

EJU0:Germany

Address

11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121

Website

https://www.aethlonmedical.com

Aethlon Medical Inc is a medical technology company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Executives

Nicolas Gikakis	director	11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO CA 92121
Lee D Arnold	officer: Chief Scientific Officer	C/O ASSEMBLY BIOSCIENCES, INC., 99 HUDSON STREET, 5TH FLOOR, NEW YORK NY 10013
Angela Rossetti	director	PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Steven P Larosa	officer: Chief Medical Officer	9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA 92123
Chetan Shah	director	9 GRACE HILL COURT, TITUSVILLE NJ 08560
Fisher Charles J Jr	director	C/O AETHLON MEDICAL, INC., 9635 GRANITE RIDGE DR., SUITE 100, SAN DIEGO CA 92123
Guy F. Cipriani	director	1727 EAGLERIDGE DRIVE, BELLINGHAM WA 98226
Sabrina Martucci Johnson	director	11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Rodell Timothy C Jr	officer: Interim CEO	201 MIDLAND AVE, ASPEN CO 81611
Weiner Family Revocable Trust Ellen R.	10 percent owner	10645 N. TATUM BOULEVARD, SUITE 200-166, PHOENIX AZ 85028
Phillip A Ward	director	8910 UNIVERSITY CENTER LANE #660, SAN DIEGO CA 92122
Thomas V Wornham	director	8910 UNIVERSITY CENTER LANE #660, SAN DIEGO CA 92122
Rodney S Kenley	director, officer: President	9635 GRANITE RIDGE DRIVE, SUITE 100, SAN DIEGO CA 92123
James B Frakes	officer: Chief Financial Officer	9635 GRANITE RIDGE DRIVE, SUITE 100, SAN DIEGO CA 92123
Barry Franklyn S Jr	director	1141 DELAWARE AVENUE #3N, BUFFALO NY 14209